Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Non Operating Income: 2022-2025

Historic Non Operating Income for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $3.0 million.

  • Gossamer Bio's Non Operating Income fell 31.11% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year decrease of 8.90%. This contributed to the annual value of $14.0 million for FY2024, which is 9.28% down from last year.
  • Latest data reveals that Gossamer Bio reported Non Operating Income of $3.0 million as of Q3 2025, which was up 9.65% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Non Operating Income ranged from a high of $6.5 million in Q2 2023 and a low of -$3.4 million during Q1 2022.
  • For the 3-year period, Gossamer Bio's Non Operating Income averaged around $3.4 million, with its median value being $3.0 million (2025).
  • In the last 5 years, Gossamer Bio's Non Operating Income soared by 370.65% in 2023 and then tumbled by 57.98% in 2024.
  • Gossamer Bio's Non Operating Income (Quarterly) stood at -$1.4 million in 2022, then skyrocketed by 370.65% to $3.8 million in 2023, then grew by 9.53% to $4.2 million in 2024, then tumbled by 31.11% to $3.0 million in 2025.
  • Its Non Operating Income stands at $3.0 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.6 million for Q1 2025.